×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
GPCR – structure therapeutics inc. - american depositary shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
GPCR
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
2/19
07:17 am
gpcr
Structure Therapeutics (GPCR) Gained from Favorable Clinical Data [Yahoo! Finance]
Low
Report
Structure Therapeutics (GPCR) Gained from Favorable Clinical Data [Yahoo! Finance]
2/18
04:52 pm
gpcr
Structure Therapeutics: The Dark Horse Has Taken The Lead - But Is It Enough? [Seeking Alpha]
Low
Report
Structure Therapeutics: The Dark Horse Has Taken The Lead - But Is It Enough? [Seeking Alpha]
2/8
04:41 pm
gpcr
Assessing Structure Therapeutics (GPCR) Valuation As GSBR-1290 Advances Through Phase 2 Obesity Trials [Yahoo! Finance]
Medium
Report
Assessing Structure Therapeutics (GPCR) Valuation As GSBR-1290 Advances Through Phase 2 Obesity Trials [Yahoo! Finance]
2/3
01:37 pm
gpcr
Obesity stocks slump on Novo's underwhelming 2026 sales forecast [Yahoo! Finance Canada]
Low
Report
Obesity stocks slump on Novo's underwhelming 2026 sales forecast [Yahoo! Finance Canada]
1/31
03:15 pm
gpcr
Key deals this week: Apple, McEwen Mining, IonQ, Leidos, and more [Seeking Alpha]
Low
Report
Key deals this week: Apple, McEwen Mining, IonQ, Leidos, and more [Seeking Alpha]
1/24
05:10 am
gpcr
Structure Therapeutics (NASDAQ:GPCR) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
Structure Therapeutics (NASDAQ:GPCR) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
1/23
06:57 am
gpcr
Structure Therapeutics (NASDAQ:GPCR) was upgraded by analysts at The Goldman Sachs Group, Inc. to a "strong-buy" rating.
Low
Report
Structure Therapeutics (NASDAQ:GPCR) was upgraded by analysts at The Goldman Sachs Group, Inc. to a "strong-buy" rating.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
2/17
04:19 pm
gpcr
Form SCHEDULE 13G/A Structure Therapeutics Filed by: BIOTECHNOLOGY VALUE FUND L P
Medium
Report
Form SCHEDULE 13G/A Structure Therapeutics Filed by: BIOTECHNOLOGY VALUE FUND L P
2/13
08:46 am
gpcr
Form SCHEDULE 13G/A Structure Therapeutics Filed by: Deep Track Capital, LP
Medium
Report
Form SCHEDULE 13G/A Structure Therapeutics Filed by: Deep Track Capital, LP
2/10
11:24 am
gpcr
Form SCHEDULE 13G/A Structure Therapeutics Filed by: WELLINGTON MANAGEMENT GROUP LLP
Low
Report
Form SCHEDULE 13G/A Structure Therapeutics Filed by: WELLINGTON MANAGEMENT GROUP LLP
2/5
01:40 pm
gpcr
Form SCHEDULE 13G/A Structure Therapeutics Filed by: FMR LLC
Low
Report
Form SCHEDULE 13G/A Structure Therapeutics Filed by: FMR LLC
1/20
09:22 am
gpcr
Form 4 Structure Therapeutics For: Jan 15 Filed by: FMR LLC
Medium
Report
Form 4 Structure Therapeutics For: Jan 15 Filed by: FMR LLC
1/5
04:08 pm
gpcr
Form 8-K Structure Therapeutics For: Dec 30
Low
Report
Form 8-K Structure Therapeutics For: Dec 30
12/10
05:07 pm
gpcr
Form 8-K Structure Therapeutics For: Dec 09
Low
Report
Form 8-K Structure Therapeutics For: Dec 09
12/10
05:04 pm
gpcr
Form 424B5 Structure Therapeutics
Low
Report
Form 424B5 Structure Therapeutics
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: